Cytogenetic and molecular mechanisms of resistance to imatinib

被引：47

作者：

Hochhaus, A ^{[1
]}

机构：

[1] Heidelberg Univ, Fak Klin Med Mannheim, Med Klin 3, D-68305 Mannheim, Germany

来源：

SEMINARS IN HEMATOLOGY | 2003年 / 40卷 / 02期

关键词：

D O I：

10.1053/shem.2003.50045

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：69 / 79

页数：11

共 57 条

[1]

Barthe C, 2001, SCIENCE, V293

[2] High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance [J].

Branford, S ;

Rudzki, Z ;

Walsh, S ;

Grigg, A ;

Arthur, C ;

Taylor, K ;

Herrmann, R ;

Lynch, KP ;

Hughes, TP .

BLOOD, 2002, 99 (09) :3472-3475

[3]

Branford S, 2001, BLOOD, V98, p769A

[4]

Buchdunger E, 1996, CANCER RES, V56, P100

[5] Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia [J].

Burchert, A ;

Wölfl, S ;

Schmidt, M ;

Brendel, C ;

Denecke, B ;

Cai, D ;

Odyvanova, L ;

Lahaye, T ;

Müller, MC ;

Berg, T ;

Gschaidmeier, H ;

Wittig, B ;

Hehlmann, R ;

Hochhaus, A ;

Neubauer, A .

BLOOD, 2003, 101 (01) :259-264

[6] Cytogenetics of chronic myeloid leukaemia [J].

Chase, A ;

Huntly, BJP ;

Cross, NCP .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (03) :553-571

[7] Analysis of the structural basis of specificity of inhibition of the Abl kinase by STI571 [J].

Corbin, AS ;

Buchdunger, E ;

Pascal, F ;

Druker, BJ .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) :32214-32219

[8] MINIMAL RESIDUAL DISEASE AFTER BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA DETECTED BY THE POLYMERASE CHAIN-REACTION [J].

CROSS, NCP ;

LIN, F ;

BUNGEY, J ;

GOLDMAN, JM .

LEUKEMIA & LYMPHOMA, 1993, 11 :39-43

[9]

CROSS NCP, 1994, LEUKEMIA, V8, P186

[10] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].

Druker, BJ ;

Sawyers, CL ;

Kantarjian, H ;

Resta, DJ ;

Reese, SF ;

Ford, JM ;

Capdeville, R ;

Talpaz, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042

← 1 2 3 4 5 6 →